Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In a message dated 9/20/2006 4:32:12 P.M. Central Standard Time, Blkeyone writes: The Center for Disease Control has issued a warning about a new virulent strain of Sexually Transmitted Disease. The disease is contracted through dangerous and high-risk behavior. The disease is called Gonorrhea Lectim and pronounced "gonna re-elect him."
Many victims contracted it in 2004, after having been screwed for the past four years. Naturalists and epidemiologists are amazed at how this destructive disease originated only a few years ago from a bush found in Texas. __._,_.___
This email was cleaned by emailStripper, available for free from http://www.papercut.biz/emailStripper.htm
Doen't matter. All real estate matters fall within his purview.There is more to the company than a production facility.
One day, a man came home and was greeted by his wife dressed in a very Sexy nightie. "Tie me up," she purred, "and you can do anything you want." So he tied her up and went golfing.
*************************************************
* A woman came home, screeching her car into the driveway, and ran into the house. She slammed the door and shouted at the top of her lungs, "Honey, pack your bags. I won the lottery!" The husband said, "Oh my God! What should I pack, beach stuff or mountain stuff?" "Doesn't matter," she said. "Just get the hell out."
************************************************** Marriage is a relationship in which one person is always right, and the other is a husband.
**************************************************
A Polish immigrant went to the DMV to apply for a driver's license. First, of course, he had to take an eye sight test. The optician showed him a card with the letters: 'C Z W I X N O S T A C Z.' "Can you read this?" the optician asked. "Read it?" the Polish guy replied, "I know the guy."
***********************************************
**
* Mother Superior called all the nuns together and said them
"I must tell you all something. We have a case of gonorrhea in the convent." "Thank God," said an elderly nun at the back. "I'm so tired of chardonnay." **************************************************
A wife was making a breakfast of fried eggs for her husband. Suddenly, her husband burst into the kitchen. "Careful," he said, "CAREFUL! Put in some more butter! Oh my GOD! You're cooking too many at once. TOO MANY! Turn them! *TURN *THEM NOW! We need more butter. Oh my GOD! WHERE are we going to get MORE BUTTER? They're going to STICK! Careful . CAREFUL! I said *be CAREFUL*! You NEVER listen to me when you're cooking! Never! Turn them! Hurry up! Are you CRAZY? Have you LOST your mind? Don't forget to salt them. You know you always forget to salt them. Use the salt. USE THE SALT! *THE SALT!" * The wife stared at him. "What in the world is wrong with you? You think I don't know how to fry a couple of eggs?" The husband calmly replied, "I just wanted to show you what it feels like when I'm driving."
**************************************************
Fifty-one years ago, Herman James, a North Carolina mountain man, was drafted by the Army. On his first day in basic training, the Army issued him a comb. That afternoon the Army barber sheared off all his hair. On his second day, the Army issued Herman a toothbrush. That afternoon the Army dentist yanked seven of his teeth. On the third day, the Army issued him a jock strap, The Army has been looking for Herman for 51 years.
Give Icahn a bit more time-
Contraryu to your naive post that job is a serious one and his performance in that role is critical to success of the company. Whom do you think was in charge of building the recently completed production facility??
Enjoy this humor, I hope not fact!!!
Idiots of 2005
Number One Idiot of 2005
I am a medical student currently doing a rotation in toxicology at the poison control center.
Today, this woman called in very upset because she caught her little daughter eating ants. I quickly reassured her that the ants are not harmful
and there would be no need to bring her daughter into the hospital. She
calmed down and at the end of the conversation happened to mention that
she gave her daughter some ant poison to eat in order to kill the ants.
I told her that she better bring her daughter into the emergency room
right away.
Here's your sign, lady. Wear it with pride.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Number Two Idiot of 2005
Early this year, some Boeing employees on the airfield decided to steal a
life raft from one of the 747s. They were successful in getting it out of
the plane and home.
Shortly after they took it for a float on the river, they noticed a Coast
Guard helicopter coming towards them. It turned out that the chopper was
homing in on the emergency locator beacon that activated when the raft
was inflated.
They are no longer employed at Boeing.
Here's your sign, guys. Don't get it wet; the paint might run.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Number Three Idiot of 2005
A man, wanting to rob a downtown Bank of America, walked into the Branch
and wrote "this iz a stikkup. Put all your muny in this bag." While
standing in line, waiting to give his note to the teller, he began to worry that
someone had seen him write the note and might call the police before he reached
the teller's window. So he left the Bank of America and crossed the street to
the Wells Fargo Bank. After waiting a few minutes in line, he handed his
note to the Wells Fargo teller. She read it and, surmising from his
spelling errors that he wasn't the brightest light in the harbor, told him that
she could not accept his stickup note because it was written on a Bank of
America deposit slip and that he would either have to fill out a Wells
Fargo deposit slip or go back to Bank of America.
Looking somewhat defeated, the man said, "OK" and left. He was arrested a
few minutes later, as he was waiting in line back at Bank of America.
Don't bother with this guy's sign. He probably couldn't read it anyway.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Number Four Idiot of 2005
A motorist was unknowingly caught in an automated speed trap that
measured his speed using radar and photographed his car.
He later received in the mail a ticket for $40 and a photo of his
car. Instead of payment, he sent the police department a photograph of
$40.
Several days later, he received a letter from the police that contained
another picture, this time of handcuffs. He immediately mailed in his
$40.
Smartass... but you still get a sign
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Number Five Idiot of 2005
A guy walked into a little corner store with a shotgun and demanded all
of the cash from the cash drawer. After the cashier put the cash in abag,
the robber saw a bottle of Scotch that he wanted behind the counter on
the shelf. He told the cashier to put it in the bag as well, but the cashier
refused and said, "Because I don't believe you are over 21." The robber
said he was, but the clerk still refused to give it to him because she didn't
believe him. At this point, the robber took his driver's license out of
his wallet and gave it to the clerk. The clerk looked it over and agreed that
the man was in fact over 21 and she put the Scotch in the bag. The robber
then ran from the store with his loot. The cashier promptly called the
police and gave the name and address of the robber that he got off the
license. They arrested the robber two hours later.
This guy definitely needs a sign.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Idiot Number Six of 2005
A pair of Michigan robbers entered a record shop nervously waving revolvers.
The first one shouted, "Nobody move!" When his partner moved, the
startled first bandit shot him.
This guy doesn't even deserve a sign
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Idiot Number Seven of 2005
Arkansas: Seems this guy wanted some beer pretty badly.
He decided that he'd just throw a cinder block through a liquor store
window, grab some booze, and run. So he lifted the cinder block and
heaved it over his head at the window. The cinder block bounced back
knocking him unconscious. It seems the liquor store window was made
of Plexi-Glass.
The whole event was caught on videotape.
Yep, Here's your sign
(Please note that all of the above people are allowed to vote.)
.
Enjoy this humor, I hope not fact!!!
Idiots of 2005
Number One Idiot of 2005
I am a medical student currently doing a rotation in toxicology at the poison control center.
Today, this woman called in very upset because she caught her little daughter eating ants. I quickly reassured her that the ants are not harmful
and there would be no need to bring her daughter into the hospital. She
calmed down and at the end of the conversation happened to mention that
she gave her daughter some ant poison to eat in order to kill the ants.
I told her that she better bring her daughter into the emergency room
right away.
Here's your sign, lady. Wear it with pride.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Number Two Idiot of 2005
Early this year, some Boeing employees on the airfield decided to steal a
life raft from one of the 747s. They were successful in getting it out of
the plane and home.
Shortly after they took it for a float on the river, they noticed a Coast
Guard helicopter coming towards them. It turned out that the chopper was
homing in on the emergency locator beacon that activated when the raft
was inflated.
They are no longer employed at Boeing.
Here's your sign, guys. Don't get it wet; the paint might run.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Number Three Idiot of 2005
A man, wanting to rob a downtown Bank of America, walked into the Branch
and wrote "this iz a stikkup. Put all your muny in this bag." While
standing in line, waiting to give his note to the teller, he began to worry that
someone had seen him write the note and might call the police before he reached
the teller's window. So he left the Bank of America and crossed the street to
the Wells Fargo Bank. After waiting a few minutes in line, he handed his
note to the Wells Fargo teller. She read it and, surmising from his
spelling errors that he wasn't the brightest light in the harbor, told him that
she could not accept his stickup note because it was written on a Bank of
America deposit slip and that he would either have to fill out a Wells
Fargo deposit slip or go back to Bank of America.
Looking somewhat defeated, the man said, "OK" and left. He was arrested a
few minutes later, as he was waiting in line back at Bank of America.
Don't bother with this guy's sign. He probably couldn't read it anyway.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Number Four Idiot of 2005
A motorist was unknowingly caught in an automated speed trap that
measured his speed using radar and photographed his car.
He later received in the mail a ticket for $40 and a photo of his
car. Instead of payment, he sent the police department a photograph of
$40.
Several days later, he received a letter from the police that contained
another picture, this time of handcuffs. He immediately mailed in his
$40.
Smartass... but you still get a sign
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Number Five Idiot of 2005
A guy walked into a little corner store with a shotgun and demanded all
of the cash from the cash drawer. After the cashier put the cash in abag,
the robber saw a bottle of Scotch that he wanted behind the counter on
the shelf. He told the cashier to put it in the bag as well, but the cashier
refused and said, "Because I don't believe you are over 21." The robber
said he was, but the clerk still refused to give it to him because she didn't
believe him. At this point, the robber took his driver's license out of
his wallet and gave it to the clerk. The clerk looked it over and agreed that
the man was in fact over 21 and she put the Scotch in the bag. The robber
then ran from the store with his loot. The cashier promptly called the
police and gave the name and address of the robber that he got off the
license. They arrested the robber two hours later.
This guy definitely needs a sign.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Idiot Number Six of 2005
A pair of Michigan robbers entered a record shop nervously waving revolvers.
The first one shouted, "Nobody move!" When his partner moved, the
startled first bandit shot him.
This guy doesn't even deserve a sign
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
Idiot Number Seven of 2005
Arkansas: Seems this guy wanted some beer pretty badly.
He decided that he'd just throw a cinder block through a liquor store
window, grab some booze, and run. So he lifted the cinder block and
heaved it over his head at the window. The cinder block bounced back
knocking him unconscious. It seems the liquor store window was made
of Plexi-Glass.
The whole event was caught on videotape.
Yep, Here's your sign
(Please note that all of the above people are allowed to vote.)
.
Reuters
ImClone changes board voting structure
Thursday September 21, 7:35 am ET
CHICAGO (Reuters) - The board of drugmaker ImClone Systems Inc. (NASDAQ:IMCL - News) said on Thursday it has changed the quorum requirement to take action from one-third to a majority.
ADVERTISEMENT
The decision was disclosed in a filing with the U.S. Securities and Exchange Commission on Thursday, the day after shareholders elected billionaire investor Carl Icahn and two of his associates to the board.
Icahn reiterated his call for the ouster of ImClone Chairman David Kies. Icahn owns 13.9 percent of ImClone's outstanding shares, worth about $390.5 million, according to a separate filing on Wednesday.
The latest filing was accompanied by a statement calling on directors to avoid "needlessly antagonistic and deliberately public debate" that it said could harm the reputation of the company.
ImClone Systems Incorporated
180 Varick Street
New York, NY 10014
Dear David:
When you offered me a directorship at ImClone in August, we discussed and Ithought you indicated that you would not continue to be the Chairman of theBoard of the Company. I also told you that it would be a mistake to give theInterim CEO a long term contract, given that he has little or no expertise inbiotech companies. I asked that you at least allow the new Board to make thisdecision. Nevertheless, without warning, ImClone entered into a multimilliondollar contract with the Interim CEO. You have also indicated that you will notbe willing to give up your chairmanship at today's meeting.
Now that I am becoming a director of ImClone, I am asking you again for the goodof ImClone and its stockholders to give up your position as Chairman of theBoard. Given what I consider the sorry record of the Company under your watch,it is time for you to step aside and allow someone else to be elected. You haveeven admitted to me that the board has done a bad job. ImClone has been withouteffective leadership for almost three years.
During your tenure, ImClone has suffered as a result of its inability to attainthe leadership position it should enjoy as an important biotechnology company.Most importantly, a great disservice has been done not only to stockholders,but, potentially, to cancer patients as well, by ImClone's apparent passivity inpushing to start appropriate trials in first-line colon cancer and otherindications.
During your tenure, I believe that commercialization has suffered, trials havenot been sufficiently pursued, the head and neck data was needlessly delayed,patent suits have been lost and the Company has not provided its stockholdersthe performance that they deserve. Rumors abound about employee dissatisfactionand probable defections.
During your tenure, ImClone hired a President and CEO who was totally the wrongperson for the position and it took you many many months to recognize this andreplace him. His replacement lasted only a few months. Now, ImClone has anotherinterim CEO and his permanent replacement is nowhere on the scene. To makematters worse, you even rewarded him with a favorable contract increasing hiscompensation and making it more expensive to replace him. This has all occurredduring the most critical period in the history of the Company in which itsability to exploit its lead in cancer treatment was being tested. Your regimehas failed the test.
During your tenure, ImClone's meaningful lead relative to potential competitorshas shrunk considerably and ImClone has suffered reversals such as the loss ofthe patent suit in the past week. I cannot believe that there were not a numberof opportunities to achieve a favorable settlement of the patent suit under yourleadership. Now the suit has been lost.
You should recognize that your leadership of ImClone should come to an immediateend. The time has come for you to peacefully pass the baton to a successor whowill be able to bring strong leadership back to ImClone. If you fail to do so,you will have thrown down the gauntlet and we will have to react accordingly.
Very truly yours,
Carl Icahn
This is so true! They always ask at the doctor's office why you are there, and you have to answer in front of others what's wrong and sometimes it is embarrassing. There's nothing worse than a Doctor's Receptionist who insists you tell her what is wrong with you in a room of other patients. I know most of us have experienced this, and I love the way this old guy handled it. An 86 year old man walked into a crowded waiting room and approached the desk.... The Receptionist said, "Yes sir, what are you seeing the Doctor for today?" "There's something wrong with my dick", he replied. The receptionist became irritated and said, "You shouldn't come into a crowded waiting room and say things like that." "Why not? You asked me wha t was wrong and I told you," he said. The Receptionist replied; "Now you've caused some embarrassment in this room full of people. You should have said there is something wrong with your ear or something, and discussed the problem further with the Doctor in private." The man replied, "You shouldn't ask people questions in a room full of strangers, if the answer could embarrass anyone." The man walked out, waited several minutes and then re-entered. The Receptionist smiled smugly and asked, "Yes??" "There's something wrong with my ear", he stated. The Receptionist nodded approvingly and smiled, knowing he had taken her advice. "And what is wrong with your ear, Sir??" "I can't piss out of it," he replied. The waiting room erupted in laughter. Mess with seniors and you're gonna lose!
Be careful--It might not work for you either
First penis transplant reversed after two weeks
Operation successful, but recipient suffered 'severe psychological problem'
Updated: 12:45 a.m. ET Sept 19, 2006
LONDON - Surgeons in China who said they performed the first successful penis transplant had to remove the donated organ because of the severe psychological problems experienced by the man and his wife.
The case appears to be the first such transplant reported in a medical journal — European Urology, published by the European Association of Urology.
The Chinese doctors could not be reached for comment, and their report does not explain how the 44-year-old man lost his penis. It says only that “an unfortunate traumatic accident” left him with a small stump, unable to urinate or have sex normally.
Surgeons led by Dr. Hu Weilie at Guangzhou General Hospital performed the complex 15-hour microsurgery to attach the penis in September 2005, a hospital spokesperson said Tuesday. The penis had been donated by the parents of a 22-year-old brain-dead man. The operation was successful but Hu and his team removed the transplant two weeks later.
“There was a strong demand from both the patient and his wife” for a transplant, and the operation “was discussed again and again” and approved by the hospital’s ethics committee, Hu wrote in the peer reviewed journal European Urology. The patient had been unable to have intercourse or urinate properly since the accident that occurred 8 months before the surgery was performed.
“Because of a severe psychological problem of the recipient and his wife, the transplanted penis regretfully had to be cut off,” Hu said in the report which was published online, without elaborating.
“This is the first reported case of penile transplantation in a human,” Hu added.
If you need a laugh, then read through these Children's Science Exam Answers.
Q: Name the four seasons.
A: Salt, pepper, mustard and vinegar.
Q: Explain one of the processes by which water can be made safe to drink
A: Flirtation makes water safe to drink because it removes large pollutants like grit, sand, dead sheep and canoeists.
Q: How is dew formed?
A: The sun shines down on the leaves and makes them perspire.
Q: How can you delay milk turning sour? (brilliant, love this)
A: Keep it in the cow.
Q: What causes the tides in the oceans?
A: The tides are a fight between the Earth and the Moon. All water tends to flow towards the moon, because there is no water on the moon, and nature hates a vacuum. I forget where the sun joins in this fight.
Q: What are steroids?
A: Things for keeping carpets still on the stairs.
Q: What happens to your body as you age?
A: When you get old, so do your bowels and you get intercontinental.
Q: What happens to a boy when he reaches puberty?
A: He says good-bye to his boyhood and looks forward to his adultery.
Q: Name a major disease associated with cigarettes
A: Premature death.
Q: What is artificial insemination?
A: When the farmer does it to the bull instead of the cow.
Q: How are the main parts of the body categorized (eg. abdomen)
A: The body is consisted into three parts - the brainium, the borax and abdominal cavity. The brainium contains the brain; the borax contains the heart and lungs, and the abdominal cavity contains the five bowels, A, E, I, O, and U.
Q: What is the fibula?
A: A small lie.
Q: What does "varicose" mean? (I do love this one...)
A: Nearby.
Q: Give the meaning of the term "Caesarean Section"
A: The Caesarean Section is a district in Rome.
Q: What does the word "benign" mean?'
A: Benign is what you will be after you be EIGHT
Another problem solved....
A British company is developing small computer chips that can store music in women's breasts.
This is considered a major breakthrough since women complain about men
staring at their breasts, and not listening to them.
Naked shorting is a very complex issue. I'd suggest you go right here on IHub to the
"Market Reform Movement on NSS/FTDS and Related Issues" message board and start reading abnout this insidious problem.
It is my firm conviction that the primary reason the SEC has made on;y minimal cosmetic changes aimed at this practice is because if they were to stamp out NSS Wall treets profits would plummet. And after all the senior leadership at the SEC comes from Wall Street and they are not about to hurt their buddies and former employers.
Rectum Stretcher
While she was "flying" down the road yesterday (10 miles over the limit), a woman passed over a bridge only to find a cop with a radar gun on the other side lying in wait. The cop pulled her over, walked up to the car, and with that classic patronizing smirk we all know and love, asked,
"What's your hurry?"
To which she replied, "I'm late for work."
"Oh yeah," said the cop, "what do you do?"
"I'm a rectum stretcher," she responded.
The cop stammered, "A what? A rectum stretcher?
And just what does a rectum stretcher do?"
"Well," she said, "I start by inserting one finger, then work my way up to two fingers, then three, then four, then with my whole hand in. I work from side to side until I can get both hands in, and then I slowly but surely stretch, until it's about 6 feet wide."
"And just what the hell do you do with a 6 foot a**hole?" he asked.
"You give him a radar gun and park him behind a bridge..........."
Traffic Ticket $95.00
Court Costs. $45.00
The Look on Cop's Face. PRICELESS
Attached Message for water, was plodding through the Iraqi desert when he saw something far off in the distance.
Hoping to find water, he walked toward the object, only to find a little old Jewish man at a small stand selling neckties. The Arab asked, "Do you have water?"
The Jewish man replied, "I have no extra water. Would you like to buy a tie? They are only $5.00."
The Arab shouted, "Idiot Jew! Israelshould not exist! I do not need an overpriced tie, I need water! I should kill you, but I must find water first!"
"OK", said the old Jew, "it does not matter that you do not want to buy a tie and that you hate me. I will show you that I am bigger than that. If you continue over that hill to the east for about two miles, you will find a lovely restaurant. It has all the water you need. Shalom."
Muttering, the Arab stumbled away over the hill. Several hours later he staggered back, near collapse, glaring at the Jewish man.
He gasped, "Your brother won't let me in without a tie."
You have this story correct.
Rectum Stretcher
While she was "flying" down the road yesterday (10 miles over the limit), a woman passed over a bridge only to find a cop with a radar gun on the other side lying in wait. The cop pulled her over, walked up to the car, and with that classic patronizing smirk we all know and love, asked,
"What's your hurry?"
To which she replied, "I'm late for work."
"Oh yeah," said the cop, "what do you do?"
"I'm a rectum stretcher," she responded.
The cop stammered, "A what? A rectum stretcher?
And just what does a rectum stretcher do?"
"Well," she said, "I start by inserting one finger, then work my way up to two fingers, then three, then four, then with my whole hand in. I work from side to side until I can get both hands in, and then I slowly but surely stretch, until it's about 6 feet wide."
"And just what the hell do you do with a 6 foot a**hole?" he asked.
"You give him a radar gun and park him behind a bridge..........."
Traffic Ticket $95.00
Court Costs. $45.00
The Look on Cop's Face. PRICELESS
NEW WEIGHT LOSS PROGRAM
A guy calls a company and orders their 5-day, 10 lb. weight loss program. The next day, there's a knock on the door and there stands before him a voluptuous, athletic, 19 year old babe dressed in nothing but a pair of Nike running shoes and a sign round her neck. She introduces herself as a representative of the weight loss company. The sign reads: -
"If you can catch me, you can have me." Without a second thought, he takes off after her. A few miles later, huffing and puffing, he finally catches her and has his way with her. The same girl shows up for the next four days and the same thing happens. On the fifth day, he weighs himself and is delighted to find he has lost 10 lb. as promised. He then calls the company and orders their 5-day/20 pound program. The next day there's a knock at the door and there stands the most stunning, beautiful, sexy woman he has ever seen in his life. She is wearing nothing but Reebok running shoes and a sign around her neck that reads: -
"If you catch me you can have me." Well, he's out the door after her like a shot! This girl is in excellent shape and it takes him a while to catch her but when he does, it's definitely worth every muscle cramp and wheeze, so for the next four days, the same routine happens. Much to his delight, on the fifth day he weighs himself only to discover that he has lost another 20 lb. as promised. He decides to go for broke and calls the company to order the 7-day/50 pound program. "Are you sure?" asks the representative on the phone - "This is our most rigorous program."
"Absolutely," he replies, "I haven't felt this good in years." The next day there's a knock at the door; and when he opens it he finds this huge, muscular, 7 ft black man standing there wearing nothing but pink running shoes and a sign around his neck that reads:-
"I'm Francis. If I catch you, you're mine..."
I have the same view-for a long time now.
NCANS Comment Letter to the SEC
Location: Blogs Bob O'Brien's Sanity Check Blog
Posted by: bobo 9/4/2006 8:12 AM
UPDATE: Folks, here is the NEWLY UPDATED NCANS letter to the SEC (as of 12AM, EST, 9/5) on Reg SHO. Please take time to read it through. It has gotten a section on penalties and loss of licensure, and a more fleshed-out section on numerical marking of individual securities - the better to ensure a one-for-one ratio of security entitlements to bona fide securities. It works with car VIN numbers and banknotes, so why not stock?
Also, we've got the first 160 or so signatures. I've been getting emails telling me that the fax is busy, so please keep trying - or email me a jpeg of your signature, or worst case, just an email authorizing me to use your name (but provide all contact info, please). If it doesn't go through, keep trying, and spread the word for anyone interested to demonstrate your support. You are either part of the problem or part of the solution - and this is where you get to decide which you are.
------------------
Special thanks to Tommytoyz for his mountain of effort in giving birth to this document, as well as to Lynn for countless hours of editing and fact-checking. Also, thanks to Patrick, and the host of others who provided input and suggestions.
This letter is intended to provide solutions, and deliberately stays away from pointing fingers or apportioning blame. Dr. Trimbath's masterful letter does an unparalleled job of describing how we got where we are, as does Dave Patch's letter. I can't think of any way of improving their observations, so we stayed away from criticism and focused on how to solve the structural problems in the market.
We would like to get as many signature to add to the document as we can, so I will ask everyone to fax a signature, and name and address, to the number below. Here is a signature form to fill out. I'll keep the addresses and phone numbers confidential, but I need them so I can substantiate that the signatures are genuine. The goal is to gather hundreds, if not thousands, of signatures to append to the letter, which will go to the SEC and be posted on the web. Please show your support, and take a moment to send us your John Hancock. And send the link to this blog to everyone you know so they can sign on as well - feel free to post it to message boards, blogs, and chat rooms. More is more. And we have about 10 days.
A fax number has been set up for signature collections. It is 702 946-0934.
Spend some time reading the document, and then get the word out so we can demonstrate support for the suggestions. A few minutes of your time can go a long way, and this is one of the ways you can make your voice heard.
Please do your part.
NewMarket Technology, Inc. Announces California Presentations of ''Next High Tech Market Wave in 3 Steps'' Lessons Learned from Startup to $50M in Profitable Revenue
Los Angeles October 3rd and Irvine October 4th
DALLAS--(BUSINESS WIRE)--Sept. 8, 2006--NewMarket Technology, Inc. (OTCBB:NMKT) today announced two additional scheduled dates to present its unique perspective on the High Tech Market. NewMarket has grown from startup to over $50 million in profitable annual revenue through 2005 and is on track to exceed $70 million in annual profitable revenue in 2006. The Company has been recognized by Deloitte as one of the fastest growing high tech companies in North America, recently being named the number one fastest growing technology company in the state of Texas. NewMarket has pioneered what the Company refers to as a Milestone Investment Strategy for capitalizing a business venture in steps and likewise providing shareholders a return on investment in steps. The strategy mitigates investor risk and still provides a high rate of return opportunity.
Philip Verges, CEO, will present "The Next High Tech Market Wave in 3 Steps" beginning September 26th and now continuing through October 4th. The presentations will be held in Atlanta on September 26th, New York on September 27th, Chicago on September 28th, Los Angeles on October 3rd and Irvine on October 4th. Anyone interested in attending or for more information, please contact wmarks@newmarkettechnology.com or Whitney Marks at 214-722-3052.
NewMarket recently announced the addition of James Mandel CEO of Multiband Corporation (NasdaqCM:MBND) to the NewMarket Board of Directors as a first step towards the two Companies exploring a strategic relationship together. Mr. Mandel brings additional high tech communications products and services experience to the management of NewMarket. Multiband is a solid communication service provider listed on NASDAQ that has shown tremendous revenue growth over the last several years from $1.4 million in 2003 to $16.5 million in 2005. Multiband is a DIRECTV (NYSE:DTV) distributor to multi resident complexes packaging additional communication services with the DIRECTV. For more information on Multiband, please visit their website at www.multibandusa
Cubist Pharmaceuticals to Present at September Investor Conferences
Wednesday August 30, 9:30 am ET
Presentations at the Thomas Weisel Partners Healthcare Conference, Bear Stearns 19th Annual Healthcare Conference, and the UBS 2006 Global Life Sciences Conference
LEXINGTON, Mass.--(BUSINESS WIRE)--Aug. 30, 2006--Cubist Pharmaceuticals, Inc. (Nasdaq: CBST - News) today announced that senior management will present at three September investor conferences. On Wednesday, September 6th, at 10:55 A.M. ET, David W. J. McGirr, SVP and CFO will present at the Thomas Weisel Partners Healthcare Conference being held at the Four Seasons Hotel in Boston. Michael Bonney, President and CEO will present on Tuesday, September 12th, at 9:00 A.M. ET, at the Bear Stearns 19th Annual Healthcare Conference being held at the Grand Hyatt in New York City. David McGirr will also present at the UBS 2006 Global Life Sciences Conference which will be held at the Park Avenue at Grand Central in New York City on September 25th at 8:00 A.M. ET. Each presentation will include a discussion of the company's business activities, financial outlook, and current news.
ADVERTISEMENT
A live webcast of each presentation will be accessible through a link on the front page of Cubist's website at www.cubist.com and also in the Investor Relations Conference Calendar section of the website. The presentations will be archived and available after the event for a period of 30 days.
About Cubist
Cubist Pharmaceuticals (nasdaq: CBST - news - people ) closed the week with a gain of 5% after a rival reported trial data for telavancin, a potential competitor to Cubist's anti-infective Cubicin. Theravance (nasdaq: THRX - news - people ) said late-stage clinical results met the primary goal of the study, but safety data was similar to previous trials, which showed a 5% to 6% increase in kidney toxicity. Morgan Stanley maintained "neutral" rating on Cubist shares. "Toxicity issues have the potential to have a major impact on the commercial viability of the drug, as we see little in these data to compel a formulary committee to choose Telavancin over Cubicin," it said. "These data represent the 'bogey' that we think investors demanded."
Cubist Shares Rise on Allayed Concerns
Wednesday August 23, 4:36 pm ET
Cubist Pharmaceuticals Shares Jump After Theravance Study Results Allay Competitive Concerns
NEW YORK (AP) -- Shares of Cubist Pharmaceuticals Inc. jumped Wednesday after a rival's late-stage drug study results allayed analysts fears the treatment would pose a competitive threat to its Cubicin drug.
ADVERTISEMENT
The stock gained $1.67, or 7.5 percent, to close at $23.93 on the Nasdaq, with average trading volume nearly tripling. The shares have traded between $16.69 and $26.77 over the last 52 weeks, and are up 5 percent year-to-date.
On Tuesday, South San Francisco, Calif.-based rival Theravance announced positive results from a late stage clinical trial on its methicillin-resistant Staphylococcus aureus infection drug, but fell short of meeting a secondary goal to treat more complicated infections caused by MRSAs. Better known as "Staph infections," MRSAs are normally limited to a small area of a person's skin but can seriously impact other parts of the body if they enter the bloodstream.
Lexington, Mass-based Cubist, also on Tuesday, filed an 8-K with the Securities and Exchange Commission that referred to results published in the New England Journal of Medicine on its Staph infection drug, Cubicin. That drug was approved in 2003 for complicated skin infections but was given expanded approval May 26 for the treatment of blood stream infections caused by Staph infections.
Cubicin sales totaled $113.5 million in 2005.
Merrill Lynch analyst David Munno released an update to investors, with his assessment that Theravance's drug, called telavancin, would not pose a competitive threat to Cubicin. Instead, he wrote, the future entry of telavancin is likely to expand the market for Cubicin. Also, the drugs will likely both take market share away from companies selling the injectible version of the antibiotic vancomycin.
He reiterated his "Buy" rating and a $35 price target.
"Ultimately, we expect telavancin approval and commercial launch will help both drugs capture market share from vancomycin," he wrote.
In the telavancin study, the drug met its primary endpoint, which was its effectiveness compared with vancomycin. But it missed its co-primary endpoint of superiority in treating Staph infections.
That leaves Cubicin's market in treating infections including endocartis, an infection of the heart, safe. Even so, if telavancin were to cut into Cubicin's market share, Cubist would not be significantly impacted as skin infection drugs make up less than 20 percent of its revenue.
Jefferies & Company Inc. analyst Eun K. Yang reiterated a "Buy" rating with a $30 price target, also citing a diminished threat of competition from telavancin.
In a note to investors, Yang focused more on some of telavancin's side effects, saying they are likely to be focused on by the Food and Drug Administration.
"We believe the toxicity profile to be a focus at the FDA and a key determinant for telavancin's potential," Yang wrote.
Shares of Theravance slid 28 cents to finish at $25 on the Nasdaq.
Strongly second your advice.
Defense Logistics Agency Contract Details
This contract was awarded on 30 May 2006. It has a total award value of $4,699770.00 (estimated).The period of performance-base yhear- is 30 May 2006-29 May 2007.
I still do not have the actual contract price for a single system but assuming it is between $1 and $1.5 million you can figure out the maximum number of systems that can be purchased on this contract. However,contracts can be amended both in total price and in period of performance if demand for units justifies such actions.
sorry--fingers didn't walk to the correct message board.
http://www.faulkingtruth.com/Articles/Commentary/1064.html
Once a Liar, Always a Liar
By Mark Faulk
August 17, 2006
From now on, don’t believe a word of anything the SEC tells you. Chances are, they’re lying. In a courtroom, they call it “impeaching the witness,” Attorneys refers to it as the “Once a liar, always a liar” scenario.
Over a year and a half after the story of a little company called Global Links Corp. was first reported by the late Gayle Essary at FinancialWire.net, Dave Patch of investigatethesec.com has exposed major fraud on Wall Street, and a blatant cover-up by the SEC. In that story, which was cited by Senator Bob Bennett in a Senate Banking Committee hearing in March of 2005, where he questioned then SEC Chairman William Bennett about naked short selling, 50 million shares were traded in the first two days after a single shareholder, Robert Simpson, bought every single share. In fact, another shareholder, Paul Flotos, bought 15% of Global Links stock after Simpson bought 100% of the company, and both shareholders registered their purchases with the SEC, claiming 115% combined ownership in a company that was still trading tens of millions of shares on a daily basis.
Now, Dave Patch has received, through the Freedom of Information Act, SEC records confirming that over ten million counterfeit shares of Global Links stock were dumped into the market immediately after the company did a reverse split and reduced the total share count to just over one million real shares. The brokers sold millions upon millions of fake shares, and the SEC covered it up. In fact, almost six million shares still remained undelivered as of the end of 2005. In classic cover-up mode, by calling the counterfeit shares “long fails” instead of “short fails,” the recent list only shows 6,800 shares short for Global Links. So…only 6,800 counterfeit “short fails,” but millions of “long fails.”
I repeat: Don’t believe a word of anything the SEC tells you.
To read the rest of this article, go to:
http://www.faulkingtruth.com/Articles/Commentary/1064.html
Is this the compeition? Click on the link--outrageous!!
We received your request for information from the diseaselista
group. Before we begin sending you the information you
requested, we want to be certain we have your permission.
-----------------------------------------------------------
CONFIRM BY VISITING THE LINK BELOW:
http://www.aweber.com/z/c/?zx7x3cq2pnv2lsbm6mpe9n0dqu3c7q1208
Click the link above to give us permission to send you
information. It's fast and easy! If you cannot click the
full URL above, please copy and paste it into your web
browser.
-----------------------------------------------------------
If you do not want to subscribe, simply ignore this message.
Thank You,
iSynergyGroup, Inc.
P.O. Box 2535, Key West, FL 33045, USA
Request generated by:
IP: 70.108.154.252
Date: August 18, 2006 07:37 EDT
Well said but you left out one very important "give" That is the opportunity to hedge funds and others to naked short its stock.
NewMarket Technology on MN1
CEO on Market News Radio To Discuss Second Quarter Results and NewMarket China
Dallas, TX (Aug. 17, 2006): Philip Verges, CEO of New Market Technology, Inc. (OTCBB:NMKT), will be live on Market News First (www.mn1.com) for an exclusive interview with the MN1 radio team. The interview is slated for Aug. 18, 2006, at 11:30 a.m. EDT.
NewMarket Technology, Inc. has combined a traditional systems integration and support services capacity with a specialized asset-based approach to assisting its clients with the delicate balance between maintaining legacy systems and gaining a competitive edge from the latest technology innovations.
The company provides certified integration and maintenance services to support the prevailing industry standard solutions to include Microsoft, Cisco Systems and Sun Microsystems with operations in China, Singapore, United States and South America.
Join Philip Verges as he discusses NewMarket Technology’s business plan and progress with Market News First on Aug. 18, 2006.
About MN1.com
Market News First is an online, market news provider that brings investors current news on the market. Market News First is the only online, live radio web site that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.
Through daily, live interviews, we bring you up to date on all the established companies and inform the investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the presidents and CFOs of companies to deliver answers to the questions that investors may ask and provides them insight into the companies present condition and future plans.
About NewMarket Technology Inc. (www.newmarkettechnology.com)
NewMarket has combined a traditional systems integration and support services capacity with a specialized asset-based approach to assisting its clients with the delicate balance between maintaining legacy systems and gaining a competitive edge from the latest technology innovations. NewMarket provides certified integration and maintenance services to support the prevailing industry standard solutions. Concurrently, NewMarket continuously seeks to acquire undiscovered emerging technology assets to incorporate into an overall product portfolio carefully packaged to complement the prevailing industry standard solutions. NewMarket ranked Number 13 on the 2005 Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America. The Company has achieved three years of rapid, profitable growth from $2.3 million in revenue in 2003 to over $50 million in 2005 and has recently increased its revenue forecast for 2006 to $70 Million.
bored tonight, nothing on TV
A gynecologist was getting tired of his job and decided to switch careers. He'd always enjoyed tinkering with engines, so he enrolled in a school for car mechanics. When the class ended, the students were given their final exam: strip a car engine completely and reassemble it in perfect working order. The gynecologist did his best - and was amazed to find he scored 150%. "How could that be?" he asked. "Well," said the instructor, "I gave you 50% for taking the engine apart. Next, I gave you 50% for reassembling it - a really fantastic job. And then I gave you a 50% bonus for doing it all through the exhaust pipe."
-----------------------------------------
A nurse walks into a bank. Preparing to endorse a check, she pulls a rectal thermometer out of her pocket and tries to write with it. She looks up at the teller, pauses for a moment, then realizing her mistake, she says, "Well, that's great...just great...some asshole's got my pen."
------------------------------------------
WHAT EVERY MAN EXPECTS IN A WIFE
She will always be beautiful and cheerful.
She could marry a movie star, but wants only you.
She will have hair that never needs curlers or beauty shops.
Her beauty won't run in a rainstorm.
She will never be sick--just allergic to jewelry and fur coats.
She will insist on moving the furniture by herself, it's good for her figure.
She will be an expert in cooking, cleaning house, fixing the car or TV, painting the house, and keeping quiet.
Her favorite hobbies will be mowing the lawn and shoveling snow.
She will hate charge cards.
Her favorite expression will be, "What can I do for you, honey?"
She will think you have Einstein's brain but look like Mr. Universe.
She will wish you would go out with the boys so that she could get some sewing done.
She will love you because you're so sexy.
WHAT HE USUALLY GETS
She speaks 140 words a minute, with gusts up to 180.
She was once a model... for a totem pole.
Where there's smoke, there she is -- cooking.
She's a light eater...once it gets light, she starts eating.
She lets you know you only have two faults: everything you do, and everything you say.
No matter what she does with it, her hair looks like an explosion in a steel wool factory.
If you get lost, open your wallet and she'll find you
The New England Journal of Medicine Publishes Results of Cubist's Landmark Study of Staphylococcus Aureus Blood Stream Infections
Wednesday August 16, 5:00 pm ET
Study Results Led to Recent Label Expansion for CUBICIN
LEXINGTON, Mass.--(BUSINESS WIRE)--Aug. 16, 2006--Cubist Pharmaceuticals, Inc. (Nasdaq: CBST - News) today announced that the New England Journal of Medicine (NEJM) has published results from the company's landmark Phase 3 study of CUBICIN® (daptomycin for injection) at 6 mg/kg as monotherapy vs. dual therapy standard of care for the treatment of patients with Staphylococcus aureus (S. aureus) blood stream infections (bacteremia) and infective endocarditis (infection of the heart valves). The study results, which are featured in the August 17, 2006 issue of the NEJM, show that CUBICIN at 6 mg/kg intravenously once daily was as effective as standard-of-care comparator for the treatment of S. aureus bacteremia including right-sided endocarditis. On May 26th, the FDA approved a supplemental New Drug Application (sNDA) to expand the indication for CUBICIN at 6 mg/kg once daily to treat patients with S. aureus blood stream infections including right-sided endocarditis.
ADVERTISEMENT
Cubist Senior Vice President and Chief Scientific Officer, Frank Tally said, "Cubist is proud to have conducted this landmark study of bacteremia and infective endocarditis caused by Staphylococcus aureus, including methicillin-resistant S. aureus or MRSA. CUBICIN is now the only therapy approved for treatment of S. aureus blood stream infections based on a prospective registration trial."
Dr. Vance Fowler, an Assistant Professor at Duke University Medical School and lead author of the paper published today, said, "As stated in this publication, treatment options for S. aureus bacteremia and endocarditis, particularly those caused by MRSA, have been limited. In an era of increasing antimicrobial resistance, and limited antimicrobial development, this study demonstrated that CUBICIN provides a much needed option for the management of S. aureus bacteremia and right-sided endocarditis." Dr. Fowler was one of the five infectious disease specialists who served as members of the Independent External Adjudication Committee (IEAC) which determined outcomes for all patients in this trial.
The study met the pre-specified criteria for the non-inferiority of CUBICIN relative to standard-of-care therapy. Standard-of-care therapy was either semi-synthetic penicillin plus initial gentamicin for infections caused by methicillin-susceptible S. aureus (MSSA), or vancomycin plus initial gentamicin for infections caused by MRSA. In the intent to treat (ITT) analysis, success rates at test of cure (TOC) were 44.2% of 120 CUBICIN-treated patients vs. 41.7% of 115 comparator-treated patients (2.4% difference (95% CI, -10.2%, 15.1%)). Success rates were similar in the patients with complicated bacteremia, and in patients with right-sided endocarditis. A safety analysis showed that the incidence of adverse events in CUBICIN and comparator treatment groups were similar. The most common adverse events occurring at an incidence of greater than or equal to 10% in both groups included anemia, diarrhea, vomiting, constipation, and nausea. Additional adverse events in the comparator group occurring at an incidence of greater than or equal to 10% included hypokalemia, renal impairment, headache, peripheral edema, and arthralgia.
S. aureus is a leading cause of bacteremia and endocarditis. Infections caused by MRSA are a serious and growing problem in the U.S. and other parts of the world. This issue of the NEJM also includes an article by lead author Dr. Gregory Moran from UCLA Medical Center, co-authored by public health experts from the U.S. Centers for Disease Control (CDC) documenting Community-associated MRSA as the most common cause of skin and soft tissue infections in emergency room patients treated in August of 2004 at university-affiliated hospitals in 11 major metropolitan areas across the United States. S. aureus was isolated from 76% of the patients in this analysis. Seventy-eight percent of the S. aureus isolates were methicillin-resistant, giving MRSA an overall prevalence in this study population of 59%.
CUBICIN was originally approved on September 12, 2003, at 4 mg/kg intravenously once daily for the treatment of complicated skin and skin structure infections (cSSSI) caused by Gram-positive organisms, including both susceptible and resistant strains of S. aureus (MSSA and MRSA respectively). These newly published findings form the basis of the sNDA filed by Cubist in September 2005 and were presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy in December 2005 and at an Anti Infective Drugs Advisory Committee meeting convened by the FDA on March 6, 2006. On May 26th, the FDA approved CUBICIN at 6 mg/kg once daily to treat patients with S. aureus blood stream infections including right-sided endocarditis, caused by MSSA and MRSA.
About CUBICIN® (daptomycin for injection)
CUBICIN is currently the only once-daily bactericidal antibiotic approved in the U.S. indicated for the treatment of complicated skin and skin structure infections caused by susceptible strains of the following Gram-positive microorganisms: Staphylococcus aureus (including methicillin-resistant strains), Streptococcus pyogenes, S. agalactiae, S. dysgalactiae subsp equisimilis and Enterococcus faecalis (vancomycin-susceptible strains only). CUBICIN is also approved in the U.S. as therapy for blood stream infections including right-sided endocarditis, caused by S. aureus. CUBICIN is not indicated for the treatment of pneumonia. Most adverse events reported in clinical trials were mild to moderate in intensity. The most common were anemia, constipation, diarrhea, nausea, vomiting, injection site reactions, and headache. To reduce the development of drug-resistant bacteria and maintain the effectiveness of CUBICIN, CUBICIN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria susceptible to CUBICIN. For full prescribing information, visit www.cubicin.com.
About blood stream infections and infective endocarditis caused by S. aureus
Normally the bacteria that live on the body's surfaces are kept in check by the immune system. When bacteria enter the bloodstream, through such means as a post surgical wound, dental work or a catheter, they can cause serious illness. With S. aureus in the bloodstream, patients are at high risk for serious complications, including deep tissue infections and infective endocarditis (IE), an infection of the heart valves. Even with prompt treatment, infective endocarditis caused by S. aureus is associated with significant morbidity and mortality.
About Cubist's landmark S. aureus bacteremia and endocarditis trial
Study DAP-IE-01-02 was an international, multi-center, prospective, randomized, controlled open-label Phase 3 trial of CUBICIN in patients with S. aureus bacteremia and endocarditis. Its end point was non-inferiority versus standard of care in both ITT and per protocol (PP) populations. Enrolled patients with S. aureus bacteremia that was either methicillin-sensitive (MSSA) or methicillin-resistant (MRSA) were randomized to receive a minimum of 2-6 weeks of either CUBICIN 6 mg/kg intravenously (IV) once-daily OR a semi-synthetic penicillin 2 grams IV 6 times per day OR vancomycin (standard doses) IV twice daily depending upon the organism susceptibility. Patients in the comparator arm of the study also received an initial 4 days of IV gentamicin, which is commonly used to reduce the duration of bacteremia. Patients were followed for up to 12 weeks following completion of therapy.
Because of the seriously ill patients involved in the study, and the fact that standard therapy exists for these conditions, this study was designed statistically as a non-inferiority study to compare CUBICIN vs. standard of care. (This is the trial design used for most "registration studies" of antibiotics.) The hurdle was for CUBICIN to be at least as effective as the comparator agents. Success at TOC--42 days following the completion of therapy--was determined by the members of the IEAC who were blinded to therapy.
About
Sometimes CNN gets stood up with an answer that they can’t mess with.
A female CNN journalist heard about a very old Jewish man who had been
going to the Western Wall to pray, twice a day, everyday, for a long,
long time. So she went to check it out. She went to the Western Wall
and there he was walking slowly up to the holy site. She watched him
pray and after about 45 minutes, when he turned to leave, using a cane
in a very slow fashion, she approac! hed him for an interview.
"I'm Rebecca Smith from CNN. Sir, how long have
you been coming to the Western Wall and praying?"
"For about 60 years."
"60 years! That's amazing! What do you pray for?"
"I pray for peace between the Christians, Jews, and the Muslims. I
pray for all the hatred to stop and I pray for all our children to
grow up in safety and friendship."
"And how do you feel after doing this for 60 years?"
"Like I'm talking to a fuckin' wall."
INTERCELL INTERNATIONAL CORP Files SEC form 10QSB, Quarterly Report
EDGAR Online (Tue 1:25pm)
Form 10QSB for INTERCELL INTERNATIONAL CORP
--------------------------------------------------------------------------------
15-Aug-2006
Quarterly Report
Item 2. Management's Discussion and Analysis
Certain statements contained in this Form 10-QSB contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties that could cause actual results to differ materially from the results, financial or otherwise, or other expectations described in such forward-looking statements. Any forward-looking statement or statements speak only as of the date on which such statements were made, and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statements are made or reflect the occurrence of unanticipated events. Therefore, forward-looking statements should not be relied upon as prediction of actual future results.
The Report of Independent Registered Public Accounting Firm on the Company's condensed consolidated financial statements as of September 30, 2005, and for each of the years in the two-year period then ended, includes a "going concern" explanatory paragraph, that describes substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to the factors prompting the explanatory paragraph are discussed below and also in Note 1 to the quarterly Financial Statements.
Management's Plans
The Company reported a net loss of $44,180 for the nine months ended June 30, 2006 ($30,037 for the three months ended June 30, 2006), and an accumulated deficit of $39,160,752 as of June 30, 2006.
On March 16, 2005, the Company (the Debtor) filed a voluntary petition for relief in the United States Bankruptcy Court, District of Colorado under Chapter 11 of Title 11 of the U.S. Bankruptcy Code. On April 5, 2006, the United States Bankruptcy Court, dismissed the Chapter 11 proceedings.
On August 7, 2006, the Company entered into an Agreement and Plan of Reorganization (the "Agreement") with NewMarket China, Inc. ("NewMarket China") and the sole shareholder of NewMarket China, NewMarket Technologies, Inc. ("NewMarket Technologies"). The Agreement provides that on the closing date, the Company will receive 1,000 restricted common shares of NewMarket China, which represents all of the issued and outstanding shares of NewMarket China in exchange for 2,000,000 shares of the Company's restricted common stock to be issued to NewMarket Technologies. The Company expects to finalize the merger on or before September 30, 2006.
NewMarket China, located in China, is the wholly-owned subsidiary of NewMarket Technologies, Inc. ("NewMarket Technologies"). NewMarket Technologies has combined a traditional systems integration and support services capacity with a specialized asset-based approach to assisting its clients with the delicate balance between maintaining legacy systems and gaining a competitive edge from the latest technology innovations. NewMarket Technologies provides certified integration and maintenance services to support the prevailing industry standard solutions.
In a separate agreement, NewMarket Technologies has agreed to purchase 1,000,000 shares of two series of preferred stock from the Company for $250,000. The funds have been put into escrow, with an unrelated third party escrow agent, with the express purpose to be used to negotiate and purchase the outstanding debt of not only the Company, but also its subsidiary, Brunetti. At June 30, 2006, approximately $58,617 worth the debt of Brunetti had been purchased. One of the series of the preferred stock will have majority voting rights. Additional terms for both series of preferred shares are in the process of being negotiated.
Results of Operations
On October 11, 2004, the Company ceased the operations of its wholly owned subsidiary, Brunetti DEC, LLC ("Brunetti"). On March 1, 2005, Brunetti filed a voluntary petition for relief in the United States Bankruptcy Court, District of Colorado under Chapter 7 of Title 7 of the U.S. Bankruptcy Code.
Loss from continuing operations for the nine months ended June 30, 2006 was $44,180 compared $177,546 for the nine months ended June 30, 2005 ($30,037 and $34,037 for the three months ended June 30, 2006 and 2005, respectively). The decrease of $133,366 for the nine months ended June 30, 2006, is explained by the decrease in general and administrative expenses as explained below.
General and administrative expenses during the nine months ended June 30, 2006 were $44,902, compared to $178,042 for the nine months ended March 31, 2005 ($30,268 and $34,064 for the three months ended June 30, 2006 and 2005, respectively). The decrease of $133,190 is primarily attributable to the decrease in operational and administrative activities as a result of the Chapter 11 proceedings.
During the nine months ended June 30, 2006, the Company recognized a net loss of $44,180 compared to a net loss of $281,586 during the nine months ended June 30, 2005($30,307 and $33,837 for the three months ended June 30, 2006 and 2005). The decrease of $237,406 is explained by an approximate $104,040 decrease in the loss from discontinued operations between 2006 and 2005 and a decrease of $133,366 in loss from continuing operations.
Liquidity and Capital Resources
During the nine months ended June 30, 2006, the Company used $22,898 in operating activities from continuing operations. The Company received a final payment of $35,000 on the work done in connection with a contract originally held by Brunetti. During the nine months ended June 30, 2006, the Company received $35,000 from financing activities from continuing operations. The $35,000 was in connection with the reduction of the $35,000 Letter of Credit placed by the Company. The Company had $35,193 of cash and cash equivalents at June 30, 2006, which is being used to support operations.
As of June 30, 2006, the Company owns approximately 0.07% of the outstanding common stock of Vyta Corp ("Vyta"). At June 30, 2006, the Company owns 23,244 shares of Vyta common stock, of which 7,500 shares are subject to warrant agreements, described below. The Company has classified its investment in Vyta as available for sale securities in which unrealized gains (losses) are recorded to shareholders' equity.
At June 30, 2006, the Company owns 15,744 shares of Vyta Corp common stock that are tradable, and based upon the closing bid price of $0.84 per share, the market value of the Vyta common shares at June 30, 2006, was $15,744. On January 31, 2006, Vyta instituted a 1 for 20 reverse split of its issued and outstanding common stock. As a result of the reverse split the number of shares held by the Company on January 31, 2006 decreased to 23,244 shares, of which 15,744 shares are tradable.
Prior to September 30, 2003, the Company entered into an agreement with an unrelated third party, to sell 5,000 shares of the Vyta common stock held by the Company along with warrants to purchase up to 15,000 restricted shares of Vyta common stock held by the Company. In exchange for the Vyta common stock and warrants, the Company received $50,000 cash. The warrants have an exercise price of $0.50 per share. The first warrant of 7,500 shares expired in October 2004. The second warrant of 7,500 shares has a term of 5 years.
The remaining warrant provides for cashless exercise and is exercisable immediately.
The warrants are considered derivative financial instruments and are therefore recorded in the balance sheet at fair value. Changes in the fair value of the warrants (unrealized gains and losses) are recognized currently in earnings (loss) of the Company. At June 30, 2006, the fair value of the derivative was estimated to be $0.
Form 10QSB for INTERCELL INTERNATIONAL CORP
--------------------------------------------------------------------------------
15-Aug-2006
Quarterly Report
Management's Plans
The Company reported a net loss of $44,180 for the nine months ended June 30, 2006 ($30,037 for the three months ended June 30, 2006), and an accumulated deficit of $39,160,752 as of June 30, 2006.
On March 16, 2005, the Company (the Debtor) filed a voluntary petition for relief in the United States Bankruptcy Court, District of Colorado under Chapter 11 of Title 11 of the U.S. Bankruptcy Code. On April 5, 2006, the United States Bankruptcy Court, dismissed the Chapter 11 proceedings.
On August 7, 2006, the Company entered into an Agreement and Plan of Reorganization (the "Agreement") with NewMarket China, Inc. ("NewMarket China") and the sole shareholder of NewMarket China, NewMarket Technologies, Inc. ("NewMarket Technologies"). The Agreement provides that on the closing date, the Company will receive 1,000 restricted common shares of NewMarket China, which represents all of the issued and outstanding shares of NewMarket China in exchange for 2,000,000 shares of the Company's restricted common stock to be issued to NewMarket Technologies. The Company expects to finalize the merger on or before September 30, 2006.
NewMarket China, located in China, is the wholly-owned subsidiary of NewMarket Technologies, Inc. ("NewMarket Technologies"). NewMarket Technologies has combined a traditional systems integration and support services capacity with a specialized asset-based approach to assisting its clients with the delicate balance between maintaining legacy systems and gaining a competitive edge from the latest technology innovations. NewMarket Technologies provides certified integration and maintenance services to support the prevailing industry standard solutions.
In a separate agreement, NewMarket Technologies has agreed to purchase 1,000,000 shares of two series of preferred stock from the Company for $250,000. The funds have been put into escrow, with an unrelated third party escrow agent, with the express purpose to be used to negotiate and purchase the outstanding debt of not only the Company, but also its subsidiary, Brunetti. At June 30, 2006, approximately $58,617 worth the debt of Brunetti had been purchased. One of the series of the preferred stock will have majority voting rights. Additional terms for both series of preferred shares are in the process of being negotiated.
Results of Operations
On October 11, 2004, the Company ceased the operations of its wholly owned subsidiary, Brunetti DEC, LLC ("Brunetti"). On March 1, 2005, Brunetti filed a voluntary petition for relief in the United States Bankruptcy Court, District of Colorado under Chapter 7 of Title 7 of the U.S. Bankruptcy Code.
Loss from continuing operations for the nine months ended June 30, 2006 was $44,180 compared $177,546 for the nine months ended June 30, 2005 ($30,037 and $34,037 for the three months ended June 30, 2006 and 2005, respectively). The decrease of $133,366 for the nine months ended June 30, 2006, is explained by the decrease in general and administrative expenses as explained below.
General and administrative expenses during the nine months ended June 30, 2006 were $44,902, compared to $178,042 for the nine months ended March 31, 2005 ($30,268 and $34,064 for the three months ended June 30, 2006 and 2005, respectively). The decrease of $133,190 is primarily attributable to the decrease in operational and administrative activities as a result of the Chapter 11 proceedings.
During the nine months ended June 30, 2006, the Company recognized a net loss of $44,180 compared to a net loss of $281,586 during the nine months ended June 30, 2005($30,307 and $33,837 for the three months ended June 30, 2006 and 2005). The decrease of $237,406 is explained by an approximate $104,040 decrease in the loss from discontinued operations between 2006 and 2005 and a decrease of $133,366 in loss from continuing operations.
Liquidity and Capital Resources
During the nine months ended June 30, 2006, the Company used $22,898 in operating activities from continuing operations. The Company received a final payment of $35,000 on the work done in connection with a contract originally held by Brunetti. During the nine months ended June 30, 2006, the Company received $35,000 from financing activities from continuing operations. The $35,000 was in connection with the reduction of the $35,000 Letter of Credit placed by the Company. The Company had $35,193 of cash and cash equivalents at June 30, 2006, which is being used to support operations.
As of June 30, 2006, the Company owns approximately 0.07% of the outstanding common stock of Vyta Corp ("Vyta"). At June 30, 2006, the Company owns 23,244 shares of Vyta common stock, of which 7,500 shares are subject to warrant agreements, described below. The Company has classified its investment in Vyta as available for sale securities in which unrealized gains (losses) are recorded to shareholders' equity.
At June 30, 2006, the Company owns 15,744 shares of Vyta Corp common stock that are tradable, and based upon the closing bid price of $0.84 per share, the market value of the Vyta common shares at June 30, 2006, was $15,744. On January 31, 2006, Vyta instituted a 1 for 20 reverse split of its issued and outstanding common stock. As a result of the reverse split the number of shares held by the Company on January 31, 2006 decreased to 23,244 shares, of which 15,744 shares are tradable.
Prior to September 30, 2003, the Company entered into an agreement with an unrelated third party, to sell 5,000 shares of the Vyta common stock held by the Company along with warrants to purchase up to 15,000 restricted shares of Vyta common stock held by the Company. In exchange for the Vyta common stock and warrants, the Company received $50,000 cash. The warrants have an exercise price of $0.50 per share. The first warrant of 7,500 shares expired in October 2004. The second warrant of 7,500 shares has a term of 5 years.
The remaining warrant provides for cashless exercise and is exercisable immediately.
The warrants are considered derivative financial instruments and are therefore recorded in the balance sheet at fair value. Changes in the fair value of the warrants (unrealized gains and losses) are recognized currently in earnings (loss) of the Company. At June 30, 2006, the fair value of the derivative was estimated to be $0.